Article Text

Download PDFPDF

Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes
Free
  1. K Vijayalakshmi1,
  2. V J Whittaker2,
  3. B Kunadian1,
  4. J Graham1,
  5. R A Wright1,
  6. J A Hall1,
  7. A Sutton1,
  8. M A de Belder1
  1. 1Department of Cardiology, The James Cook University Hospital, Middlesbrough, UK
  2. 2School of Health and Social Care, University of Teesside, Middlesbrough, UK
  1. Correspondence to:
    Dr Mark A de Belder
    Department of Cardiology, The James Cook University Hospital, Marton Road, Middlesbrough TS4 3BW, UK; mark.debelder{at}stees.nhs.uk

Abstract

Objectives: To study the impact of injection of verapamil and adenosine in the coronary arteries on TIMI (Thrombolysis in Myocardial Infarction) frame count (TFC) after percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome (ACS).

Methods: Prospective, randomised, controlled study of the intracoronary administration of normal saline versus verapamil versus adenosine in patients undergoing PCI in the setting of an ACS, even when flow is visually established to be normal or near normal. Patients were randomised to receive verapamil (n  =  49), adenosine (n  =  51) or normal saline (n  =  50) after PCI. Quantitative angiography, TIMI flow grade (TFG), TFC and myocardial blush grade were assessed before PCI, after PCI and after drugs were given. Wall motion index (WMI) was measured at days 1 and 30.

Results: 9 patients in the verapamil group developed transient heart block, not seen with adenosine (p ⩽ 0.001). Compared with saline, coronary flow measured by TFC improved significantly and WMI improved slightly but insignificantly in both the verapamil (TFC: p  =  0.02; mean difference in improvement in WMI: 0.09, 95% confidence interval (CI) 0.015 to 0.17, p  =  0.02) and the adenosine groups (TFC: p  =  0.002; mean difference in improvement in WMI: 0.08, 95% CI 0.004 to 0.16, p  =  0.04). The improvements in TFC and WMI did not differ significantly between the verapamil and the adenosine groups (TFC: p  =  0.2; mean difference in improvement in WMI: 0.01, 95% CI −0.055 to 0.08, p  =  0.7, respectively).

Conclusion: Administration of verapamil or adenosine significantly improves coronary flow and WMI after PCI in the setting of an ACS. Flow and WMI did not differ significantly between verapamil and adenosine but verapamil was associated with the development of transient heart block.

  • ACS, acute coronary syndrome
  • MBG, myocardial blush grade
  • PCI, percutaneous coronary intervention
  • PTCA, percutaneous transluminal coronary angioplasty
  • RCA, right coronary artery
  • STEMI, ST elevation myocardial infarction
  • TFC, TIMI frame count
  • TFG, TIMI flow grade
  • TIMI, Thrombolysis in Myocardial Infarction
  • WMI, wall motion index

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Published Online First 31 January 2006

  • Competing interests: None declared.